Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study
Title:
Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study
Author:
Van Cutsem, E. Yoshino, T. Lenz, H.J. Lonardi, S. Falcone, A. Limón, M.L. Saunders, M. Sobrero, A. Park, Y.S. Ferreiro, R. Hong, Y.S. Tomasek, J. Taniguchi, H. Ciardiello, F. Stoehr, J. Oum’Hamed, Z. Vlassak, S. Studeny, M. Argiles, G.